U.S. research firm Thomson Reuters is a leading candidate for the Nobel Prize in Physiology or Medicine and Chemistry. We listed three Japanese directors of the new drug development field at the Development Center.
Thomson Reuters uses the company's citation database to extract articles with extremely high citations.He gave the researcher the "Thomson Reuters Citation Honor Award" and announced it as a leading candidate for the Nobel Prize of the year.
According to Thomson Reuters, Professor Honjo discovered "PD-1", a protein that suppresses the action of immune cells.Professor Maeda and Director Matsumura have developed a "drug delivery system" that targets cancer cells and sends drugs.Since there is a strong correlation between the number of citations of academic papers and the evaluation of Nobel laureates, there are voices in domestic and overseas academic societies expecting the three awards.
From Dr. Hideki Yukawa in 1949 to Dr. Satoshi Omura in 2015, the Japanese Nobel Prize winners are 10 Physics Prizes, 7 Chemistry Prizes, 3 Physiology / Medical Prizes, 2 Literature Prizes, and 1 Peace Prize. There are a total of 23 people.
Professor Tasuku Honjo commented on receiving the Thomson Reuters Citation Laureate Award, saying, "It is a great honor to be selected for this award. It is my greatest pleasure that our research has helped treat cancer and saved human lives." Announced comments.
